Literature DB >> 12902162

Telomere maintenance and DNA replication: how closely are these two connected?

Mikhail Chakhparonian1, Raymund J Wellinger.   

Abstract

The maintenance of the DNA at chromosome ends, the telomeres, depends on conventional semiconservative replication and on the action of telomerase, a specialized reverse transcriptase. Current research strongly suggests a regulatory interplay between this conventional semiconservative replication and telomerase, thus ensuring that no sequences are lost at the very ends of the telomeres during replication. Here, we describe recent findings on the interactions between the conventional replication machinery and telomere replication, and we discuss how DNA-integrity checkpoints might impinge on both the processing of the telomeric DNA ends and the establishment of the DNA end structure required for end protection and genome stability.

Mesh:

Year:  2003        PMID: 12902162     DOI: 10.1016/S0168-9525(03)00135-5

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  33 in total

1.  MRX-dependent DNA damage response to short telomeres.

Authors:  Valeria Viscardi; Diego Bonetti; Hugo Cartagena-Lirola; Giovanna Lucchini; Maria Pia Longhese
Journal:  Mol Biol Cell       Date:  2007-05-30       Impact factor: 4.138

2.  Subtelomeric proteins negatively regulate telomere elongation in budding yeast.

Authors:  Anne-Sophie Berthiau; Krassimir Yankulov; Amadou Bah; Emmanuelle Revardel; Pierre Luciano; Raymund J Wellinger; Vincent Géli; Eric Gilson
Journal:  EMBO J       Date:  2006-02-09       Impact factor: 11.598

3.  Mutant telomeric repeats in yeast can disrupt the negative regulation of recombination-mediated telomere maintenance and create an alternative lengthening of telomeres-like phenotype.

Authors:  Laura H Bechard; Bilge D Butuner; George J Peterson; Will McRae; Zeki Topcu; Michael J McEachern
Journal:  Mol Cell Biol       Date:  2008-11-24       Impact factor: 4.272

4.  Distinct roles for yeast Stn1 in telomere capping and telomerase inhibition.

Authors:  Andrea Puglisi; Alessandro Bianchi; Laure Lemmens; Pascal Damay; David Shore
Journal:  EMBO J       Date:  2008-09-03       Impact factor: 11.598

5.  Telomere extension occurs at most chromosome ends and is uncoupled from fill-in in human cancer cells.

Authors:  Yong Zhao; Agnel J Sfeir; Ying Zou; Christen M Buseman; Tracy T Chow; Jerry W Shay; Woodring E Wright
Journal:  Cell       Date:  2009-08-07       Impact factor: 41.582

Review 6.  Psychiatric disorders and leukocyte telomere length: Underlying mechanisms linking mental illness with cellular aging.

Authors:  Daniel Lindqvist; Elissa S Epel; Synthia H Mellon; Brenda W Penninx; Dóra Révész; Josine E Verhoeven; Victor I Reus; Jue Lin; Laura Mahan; Christina M Hough; Rebecca Rosser; F Saverio Bersani; Elizabeth H Blackburn; Owen M Wolkowitz
Journal:  Neurosci Biobehav Rev       Date:  2015-05-18       Impact factor: 8.989

7.  Yeast telomere capping protein Stn1 overrides DNA replication control through the S phase checkpoint.

Authors:  Hovik J Gasparyan; Ling Xu; Ruben C Petreaca; Alexandra E Rex; Vanessa Y Small; Neil S Bhogal; Jeffrey A Julius; Tariq H Warsi; Jeff Bachant; Oscar M Aparicio; Constance I Nugent
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-26       Impact factor: 11.205

8.  Human telomeres maintain their overhang length at senescence.

Authors:  Weihang Chai; Jerry W Shay; Woodring E Wright
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

9.  Fission yeast Dna2 is required for generation of the telomeric single-strand overhang.

Authors:  Kazunori Tomita; Tatsuya Kibe; Ho-Young Kang; Yeon-Soo Seo; Masahiro Uritani; Takashi Ushimaru; Masaru Ueno
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

10.  The MRX complex plays multiple functions in resection of Yku- and Rif2-protected DNA ends.

Authors:  Diego Bonetti; Michela Clerici; Nicola Manfrini; Giovanna Lucchini; Maria Pia Longhese
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.